HRS4R
Vull donar
Fernández-Real JM, Equitani F, Moreno JM, Manco M, Ortega F, Ricart W

Study of Circulating Prohepcidin in Association with Insulin Sensitivity and Changing Iron Stores

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94, 982-988 dx.doi.org/10.1210/jc.2008-1211
Ibáñez L, López-Bermejo A, Díaz M, Enríquez G, del Río L, de Zegher F

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months

CLINICAL ENDOCRINOLOGY, 2009, 71, 351-357 dx.doi.org/10.1111/j.1365-2265.2008.03472.x
Gort L, Quintana E, Moliner S, González-Quereda L, López-Hernández T, Briones P

An update on the molecular analysis of classical galactosaemia patients diagnosed in Spain and Portugal: 7 new mutations in 17 new families.

MEDICINA CLINICA, 2009, 132, 709-711 dx.doi.org/10.1016/j.medcli.2008.11.031
Sucunza N, Barahona MJ, Resmini E, Fernández-Real JM, Ricart W, Farrerons J, Rodríguez Espinosa J, Marin AM, Puig T, Webb SM

A Link between Bone Mineral Density and Serum Adiponectin and Visfatin Levels in Acromegaly

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94, 3889-3896 dx.doi.org/10.1210/jc.2009-0474
Simón I, Escoté X, Vilarrasa N, Gómez J, Fernández-Real JM, Megía A, Gutiérrez C, Gallart L, Masdevall C, Vendrell J

Adipocyte Fatty Acid-binding Protein as a Determinant of Insulin Sensitivity in Morbid-obese Women

Obesity, 2009, 17, 1124-1128 dx.doi.org/10.1038/oby.2008.665
Brugada P, Benito B, Brugada R, Brugada J

Brugada syndrome: update 2009.

HELLENIC JOURNAL OF CARDIOLOGY, 2009, 50, 352-372
Freixa X, Sionis A, Castel A, Guasch E, Loma-Osorio P, Arzamendi D, Roig E, Perez-Villa F

Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis.

TRANSPLANTATION PROCEEDINGS, 2009, 41, 2234-2236 dx.doi.org/10.1016/j.transproceed.2009.06.012
Grau M, Baena-Díez JM, Ramos R, Marrugat J

Reflections on Cardiovascular Risk Estimates in Primary Prevention Response

REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62, 229-230 dx.doi.org/10.1016/S0300-8932(09)70172-1
Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells.

CELL CYCLE, 2009, 8, 88-96 dx.doi.org/10.4161/cc.8.1.7499
Ortega FJ, Moreno-Navarrete JM, Ribas V, Esteve E, Rodriguez-Hermosa JI, Ruiz B, Peral B, Ricart W, Zorzano A, Fernández-Real JM

Subcutaneous Fat Shows Higher Thyroid Hormone Receptor-alpha 1 Gene Expression Than Omental Fat

Obesity, 2009, 17, 2134-2141 dx.doi.org/10.1038/oby.2009.110
Handberg A, Lopez-Bermejo A, Bassols J, Vendrell J, Ricart W, Fernandez-Real JM

Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men

DIABETES & VASCULAR DISEASE RESEARCH, 2009, 6, 15-20 dx.doi.org/10.3132/dvdr.2009.003
Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB, Fernandez-Balsells MM, Albuquerque FN, Lampropulos JF, Erwin PJ, Smith SA, Montori VM

Aspirin for the Primary Prevention of Cardiovascular Events A systematic review and meta-analysis comparing patients with and without diabetes

Diabetes Care, 2009, 32, 2300-2306 dx.doi.org/10.2337/dc09-1297
Ibáñez L, López-Bermejo A, Díaz M, Marcos MV, Casano P, de Zegher F

Abdominal Fat Partitioning and High-Molecular-Weight Adiponectin in Short Children Born Small for Gestational Age

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94, 1049-1052 dx.doi.org/10.1210/jc.2008-2176
Benito B, Brugada R, Brugada J, Brugada P

Brugada syndrome.

PROGRESS IN CARDIOVASCULAR DISEASES, 2008, 51, 1-22 dx.doi.org/10.1016/j.pcad.2008.05.002
Lupu R, Colomer R, Menéndez JA

An easy, rapid and objective mathematical method to identify fatty acid synthase (oncogenic antigen-519) modulators with potential anticancer value.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10, 219-226 dx.doi.org/10.1007/s12094-008-0185-x
López-Bermejo A, Botas-Cervero P, Ortega-Delgado F, Delgado E, García-Gil MM, Funahashi T, Ricart W, Fernández-Real JM

Association of ADIPOR2 with liver function tests in type 2 diabetic subjects

Obesity, 2008, 16, 2308-2313 dx.doi.org/10.1038/oby.2008.344
Equitani F, Fernandez-Real JM, Menichella G, Koch M, Calvani M, Nobili V, Mingrone G, Manco M

Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations

Diabetes Care, 2008, 31, 3-8 dx.doi.org/10.2337/dc07-0939
López-Bermejo A, de Zegher F, Díaz-Silva M, Vicente MP, Valls C, Ibáñez L

Cord serum visfatin at term birth: maternal smoking unmasks the relation to foetal growth

CLINICAL ENDOCRINOLOGY, 2008, 68, 77-81 dx.doi.org/10.1111/j.1365-2265.2007.03002.x
Moldes O, Sobrino T, Millán M, Castellanos M, Pérez de la Ossa N, Leira R, Serena J, Vivancos J, Dávalos A, Castillo J

High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA.

Stroke, 2008, 39, 2006-2010 dx.doi.org/10.1161/STROKEAHA.107.495044
Benito B, Brugada R, Perich RM, Lizotte E, Cinca J, Mont L, Berruezo A, Tolosana JM, Freixa X, Brugada P, Brugada J

A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation.

Heart Rhythm, 2008, 5, 1434-1440 dx.doi.org/10.1016/j.hrthm.2008.07.013

Coneix l’IDIBGI!

menu